Deals like this often don't disclose the terms (as is the case in this particular agreement). We are very excited as this is an example of a de-risking success -- meaning that strategic support over the last several years from MJFF (along with Cure Parkinson's Trust and Parkinson's UK) has advanced this program sufficiently to secure critical funds from a development partner.

There have been several other successes in the last weeks ... just what we are going for! Great news for the PD drug development pipeline.

Debi